Viewing Study NCT00301639



Ignite Creation Date: 2024-05-05 @ 4:44 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00301639
Status: COMPLETED
Last Update Posted: 2011-07-12
First Post: 2006-03-10

Brief Title: A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy Of Two Long-Acting Formulations of Methylphenidate in Adults
Sponsor: Massachusetts General Hospital
Organization: Massachusetts General Hospital

Study Overview

Official Title: A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy Of Two Long-Acting Formulations of Methylphenidate in Adults
Status: COMPLETED
Status Verified Date: 2011-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The specific aim of this study is to document the pharmacokinetics of dopamine transporter DAT receptor occupancy of OROS MPH and Metadate CD using PET scanning with C-11 Altropane as the ligand We hypothesize that CNS DAT occupancy of OROS MPH will be greater than that of Metadate CD at 10 hours after administration
Detailed Description: OROS-MPHs pharmacokinetic profile uses an increasing delivery of MPH over the day ascending pharmacokinetic curve It was designed to replace IR-MPH TID treatment Another new long-acting formulation is Metadate CD Metadate CD consists of capsules with two types of beads It was designed to replace IR-MPH BID treatment The main target of MPH in the brain is the dopamine transporter DAT We have an exquisitely sensitive methodology to measure DAT occupancy using C-11 Altropane and Positron Emission Tomography PET The time course of decay of the C-11 Altropane permits repeated imaging thus allowing documentation of the pharmacokinetics of DAT receptor occupancy

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None